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Abstract Cytoplasmic acidification has been shown to occur 
during the apoptotic process of cell death although its relation 
with other events in the process are not yet clear. AK-5 tumor 
cells have been shown to undergo apoptosis upon treatment with 
stimuli like dexamethasone (1 uM) or with serum from animals 
that reject AK-5 tumor. The current study was designed to 
measure the extent of cytoplasmic acidification during apoptosis 
in AK-5 cells and to study the effect of antiapopoptic genes and 
peptide inhibitors on cytoplasmic acidification. Our results show 
that AK-5 cells when triggered into apoptosis show intracellular 
acidification by about 0.2 pH units and this is prevented when 
cells are treated with peptide inhibitors. In addition cytoplasmic 
acidification does not occur when AK-5 cells are transfected with 
anti-apoptotic genes Nedd-2 A.S, Crm A or bcl-2 which inhibit 
apoptosis. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Apoptosis is now a well recognized process of cell death 
which occurs mainly under physiological conditions wherein 
the cell actively participates in its own death. The detailed 
mechanism of induction of apoptosis or the nature of the 
signalling molecules that transmit the apoptotic signal into 
the nucleus is not yet well understood. However, the execution 
phase of the apoptotic program is better understood and sev-
eral cysteine proteinases [1,2] and specific endonucleases [3] 
have been implicated in this phase. One of the endonucleases 
involved in apoptosis has been shown to be activated by low-
ering of intracellular p H [pH]; [4]. Recently the intracellular 
acidification has been shown to result from a change in the 
setpoint of the N a + / H + - a n t i p o r t which may result from its 
dephosphorylation [5]. 
The importance of proteolysis in apoptosis is well estab-
lished from the genetic analysis in C. elegans [6]. Similarly 
the mammalian homologs of the ced family of genes which 
participate in apoptosis are also known [1,2,7]. Bcl-2, which is 
an anti-apoptotic gene similar to ced-9 inhibits the cysteine 
protease activity [8] and has also been shown to act at a point 
upstream of protease activation and acidification [9]. Thus 
intracellular acidification is considered to be an essential event 
in the apoptotic program of a cell. 
We have been studying the mechanisms involved in the 
spontaneous regression of a rat histiocytoma, AK-5 [10], 
and have demonstrated the participation of natural killer 
(NK) cells in antibody-dependent cellular cytotoxicity 
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(ADCC) [11]. AK-5 cells are killed by N K cells through ne-
crosis and apoptosis [12] both in vitro [13] and in vivo [14]. 
Cysteine proteinases like interleukin-lp converting enzyme 
(ICE) (caspase-1), YAMA/CPP32 (caspase-3) and Nedd-2 
(caspase-2) participate in the execution phase of apoptosis in 
AK-5 cells and bcl-2 gene product inhibits the apoptosis com-
pletely (unpublished observations). In the present investiga-
tion we have measured the extent of intracellular acidification 
while the tumor cell is undergoing apoptosis, using a fluores-
cent probe 2',7'-bis-(-2 carboxyethyl)-5,6 carboxy-fluorescein 
acetomethoxy ester (BCECF-AM). We also studied the p H 
changes in the presence of cysteine protease inhibitors (like 
YVAD, ester DEVD) and CrmA. Similarly intracellular acid-
ification induced by apoptotic stimuli in AK-5 cells trans-
fected with the bcl-2 gene was also studied. Results presented 
suggest a correlation of intracellular acidification with apop-
tosis, as change in [pH] ; was not seen in the presence of in-
hibitors of apoptosis. 
2. Materials and methods 
2.1. Tumor and cell line 
AK-5 tumor which is maintained as ascites was adapted to grow for 
several generations in DMEM with 10% FCS in the presence of pen-
icillin (100 U/ml) and streptomycin (50 (ig/ml). A single cell clone of 
AK-5 called BC-8 has been used in these studies to avoid ambiguity in 
results due to tumor heterogeneity [15]. 
2.2. Apoptosis assay and isolation of serum factor 
BC-8 cells (1X106) were incubated with serum (45% ammonium 
sulfate fraction of anti-AK-5 serum) (10%) or dexamethasone 
(DEX, 1 uM) for different time periods. The cells were washed, fixed 
in ethanol and stained with propidium iodide (PI) and analyzed by 
flow cytometry. 
For isolating the serum factor, serum from rats that had rejected 
the solid tumor after rechallenging with 5X106 AK-5 cells intraper-
itoneally, was collected. The sera from different animals were tested 
for the presence of anti-AK-5 antibody by their ability to lyse AK-5 
cells through complement fixation and positive samples were pooled. 
Ten milliliters of anti-AK-5 serum was diluted with phosphate-buff-
ered saline (PBS), 22.5 g of ammonium sulfate was added, volume 
made up to 50 ml (to give 45% ammonium sulfate fraction) and was 
kept at 4°C for 4 h with constant stirring. At the end of 4 h, the serum 
was spun at 12000Xg in HB-4 rotor for 20 min. The precipitate was 
washed, dissolved in 2 ml of cold PBS and dialysed overnight with 
three changes of PBS at 4°C to remove traces of ammonium sulfate in 
the sample. This is referred to as serum factor. 
2.3. Propidium iodide staining and flow cytometry 
BC-8 cells after the apoptosis assay were washed with PBS, and 
fixed in 70%> ethanol. Tumor cells were stained with PI reagent (Cal-
biochem, 50 ug/ml in 0.1% sodium citrate containing 0.1% Triton X-
100) and analyzed under fluorescent microscope. 
2.4. DNA extraction and electrophoresis 
Fixed tumor cells were washed, suspended in citrate-phosphate 
buffer and the fragmented DNA was extracted following the previ-
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ously published procedure [16]. Fragmented DNA with loading buffer 
was electrophoresed on 0.86% agarose gel at 2 V/cm for 16 h. DNA in 
the gels was visualized under UV light after staining with 5 ug/ml 
ethidium bromide. 
2.5. DNA transfections and cloning 
BC-8 cells (2 X 106) were transfected with 5 ug of the linearized 
plasmids, CrmA [7], Nedd-2 A.S [17] and bcl-2 [18] by electroporation 
method as described earlier [19]. Geneticin (G418) was added (400 ug/ 
ml) and the cells were selected for 14 days. Bcl-2 transfected clones 
were selected with hygromycin B (400 ug/ml) for 14 days. Single cell 
clones were obtained by limiting dilution procedure. Clones were 
screened by Southern and Northern hybridizations and the positive 
clones were expanded and used in the studies. 
2.6. Treatment with protease inhibitors 
BC-8 cells and the transfected clones were pre-incubated with cys-
teine protease inhibitors Ac-YVAD-cmk and Ac-DEVD-CHO (Bach-
em, Switzerland) for 30 min prior to their treatment with the inducers 
of apoptosis. After a preliminary titration of the peptide inhibitors, 
YVAD and DEVD were used at a concentration of 50 uM and 400 
uM, respectively. Control cells were treated with appropriate concen-
trations of DMSO or ethanol the solvent in which the peptide inhib-
itors were dissolved. These cells were processed for pH measurements. 
2.7. Measurement of intracellular pH 
Change in [pH]j was measured using BCECF-AM as described ear-
lier [20]. Specifically BC-8 cells and the transfected clones (2x 106 cells 
in 2 ml) were treated with BCECF-AM at a final concentration of 
1 uM. After 30 min of incubation with BCECF-AM, cells were 
washed to remove external probe resuspended in DMEM-FCS and 
treated with apoptotic stimuli, DEX (1 uM) or serum factor (10%) or 
with peptide inhibitors for different periods of times. At the end of the 
treatment cells were washed and resuspended in PBS-MOPS and used 
for fluorescence measurements. 
Preliminary observations indicated 90 and 180 min incubation as 
the optimal time for the induction of apoptosis related pH changes 
induced by DEX and serum factor, respectively. It is to be noted that 
there is no change in the maximum fluorescence intensity observed in 
a particular sample over a period of time. Therefore the lowering of 
fluorescence intensity after the addition of DEX or serum factor most 
probably reflects intracellular acidification. Standard curve for the 
pH-dependent fluorescence of BCECF was generated as described 
earlier [20]. Briefly 2X 107 cells were loaded with the fluorescent probe 
for 30 min, the cells were washed, resuspended in 20 ml of PBS-MOPS 
containing 0.1% Triton X-100 and homogenized. The homogenate 
was centrifuged at 10000 rpm in HB-4 rotor (15 000Xg) to remove 
the cell debris and pH of 3 ml volumes of it was adjusted to different 
values between 6 and 8. Standard curve was generated after recording 
the fluorescence spectra and peak intensity at 530 nM of the cell 
lysates at different pH values. 
3. Results 
3.1. Induction of apoptosis 
AK-5/BC-8 tumor cells undergo apoptosis when treated 
Table 1 
pH changes in BC-8 cells after induction of apoptosis8 
Group Incubation time(min) pH 
Control 
Control 
+DEX 
+Serum factor 
+DEX+YVAD 
+Serum factor+YVAD 
+DEX+DEVD 
+Serum factor+DEVD 
90 
180 
90 
180 
90 
180 
90 
180 
6.63 
6.12 
6.44 (0.19) 
6.32 (0.20) 
6.54 (0.09) 
6.15 (0.03) 
6.63 (0.00) 
6.47 (0.35)b 
aBC-8 cells (5X106) were incubated with BCECF-AM, washed and 
treated with either DEX or the serum factor. 2 X106 cells were 
washed, suspended in PBS and the fluorescence spectra were recorded. 
pH units were calculated from the standard curve generated for the 
dye at different pH values. The values shown are representative of 
5 similar experiments 
bThis increase in pH by 0.35 U as compared to the control cannot be 
explained as of now. 
with either D E X or with the serum of tumor-bearing animals. 
However, the identity of the serum factor that induces apop-
tosis is not yet clear. Tumor cells show condensation of chro-
matin and formation of apoptotic bodies in the presence of 
serum factor (Fig. 1). Similarly when BC-8 cells are treated 
with DEX, there is fragmentation of cellular DNA which is 
typical of apoptotic cells (Fig. 2). Apoptosis of AK-5 cells 
plays an important role in the death of tumor cells leading 
to spontaneous regression of the tumor [14]. We have also 
demonstrated the participation of cysteine proteinases ICE, 
CPP32/YAMA and Nedd-2 in the execution of apoptosis in 
BC-8 cells (unpublished observations). 
3.2. Changes in intracellular pH after induction of apoptosis 
Changes in the internal pH of the cells [pH]j was measured 
using a pH-dependent fluorescent probe BCECF-AM. Fig. 3 
shows the corrected fluorescence spectra of the dye taken up 
by the BC-8 cells and after treatment with the apoptotic in-
ducers, DEX (Fig. 3A) and the serum factor (Fig. 3B). As can 
be seen there is a reduction in fluorescence intensity of 
BCECF taken up by cells in the presence of DEX and serum 
factor. The corrected spectra presented here are free from 
influences due to wavelength characteristic of the analysis sys-
tem. Fluorescence spectra of BCECF in the cell lysates ad-
justed to different pH values were recorded and a standard 
curve as generated by plotting fluorescence intensity versus 
pH. DEX, which is an inducer of apoptosis in BC-8 cells 
shows the lowering of pH by 0.19 U as compared to the 
appropriate control (Fig. 3A, spectra a and b and Table 1). 
Fig. 1. AK-5 tumor cells treated with serum factor. A: Control. B: Serum-treated cells (notice the formation of apoptotic bodies when treated 
with serum factor). 
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Fig. 2. Induction of DNA fragmentation in AK-5 cells after treat-
ment with dexamethasone for 16 h. Lanes 1, control; lanes 2 and 3, 
dexamethasone-treated cells. 
Similarly, serum factor induced a pH change of 0.20 U (Fig. 
3B, spectra c and d and Table 1). There was no lowering of 
[pH]; or the acidification was less in the presence of inhibitors 
of apoptosis DEVD and YVAD in BC-8 cells (Table 1). 
3.3. Inhibition of apoptosis and intracellular acidification 
In order to confirm that the pH changes observed in BC-8 
cells were due to the induction of apoptosis induced by DEX 
or serum factor, we introduced inhibitors of cysteine protein-
ase genes Nedd-2 A.S, CrmA or Bcl-2 into BC-8 tumor cells 
by DNA transfection procedures. Nedd-2 in antisense orien-
tation (Nedd-2 A.S) inhibits Nedd-2 protease [17], similarly 
CrmA is a specific inhibitor for ICE protease [7] and bcl-2 has 
been shown to act upstream of cysteine proteases and thus 
acts as a strong inhibitor of apoptosis [18]. There was no 
significant change in the internal pH in all the three trans-
fected clones which expressed inhibitors of proteases in the 
presence of DEX or serum factor (Table 2). These results 
confirm our earlier observations that pH change of the order 
Table 2 
Apoptosis related pH changes in BC-8 cells and the transfected 
clones8 
Group PH 
Control DEX Serum factor 
BC-8 
Nedd-A.S 
CrmA 
Bcl-2 
6.63 
6.50 
6.50 
6.45 
6.44 (0.19) 
6.48 (0.02) 
6.47 (0.03) 
6.49 (0.04) 
6.52 (0.11) 
n.d. 
n.d. 
6.39 (0.06) 
"BC-8 control cells and the transfected clones were incubated with 
BCECF-AM and induced for apoptosis with DEX or the serum fac-
tor. The values shown are representative of 3 similar experiments. 
n.d. denotes not determined. 
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Fig. 3. Corrected spectra of BCECF-AM taken up by AK-5 cells 
treated with inducers of apoptosis, dexamethasone or serum factor. 
AK-5 cells were incubated with BCECF-AM for 30 min in DMEM 
buffered with MOPS, washed and resuspended in DMEM-MOPS in 
the presence and absence of dexamethasone (1 uM) for 90 min or 
serum factor (10%) for 180 min as described in Section 2. Cells 
were pelleted, washed and resuspended in PBS-MOPS and the spec-
tra of the cells were recorded. Keeping the excitation wavelength at 
500 nm and excitation and emission bandpass at 3 nm each. (A) a, 
control; b, dexamethasone for 90 min. (B) c, control; d, serum fac-
tor for 180 min. 
of about 0.2 U corresponds to the apoptotic process initiated 
by either DEX or serum in these cells. 
4. Discussion 
Acidification of cells undergoing apoptosis is a well recog-
nized feature established in a variety of systems [5,9,21]; how-
ever its relation to other events in the apoptotic process are 
not known. It is also thought that the cytoplasmic acidifica-
tion may be an irreversible event, which may be serving as a 
global switch to inactivate normal cellular processes operating 
at neutral pH. HL-60 and ML-1 cells when induced into 
apoptotic program with anticancer drug, etoposide, showed 
a discrete population of cells with a pH of about 0.7 U below 
that of control cells [22]. 
Cells have been shown to regulate their pH through a vari-
ety of ion transport mechanisms, including Na+/H+-antiports 
[5]. A wide variety of external signals including growth factors 
have been shown to enhance the affinity of the antiport for 
H+ which is also dependent on phosphorylation [23]. 
Apoptosis or programmed cell death is a physiological 
process during development, tissue remodelling and cell turn-
over [24]. Regulation of apoptosis plays a crucial role in many 
pathological conditions including cancer, AIDS and neurode-
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generation [25]. The importance of understanding the mecha-
nisms of induction of apoptosis in tumor cells is enormous for 
cancer therapy. Recent genetic and biochemical studies have 
suggested that proteases and endonucleases play a prominent 
role in the execution phase of the apoptotic cell death. We 
have also evidence to suggest the participation of ICE-like 
proteases in the apoptosis of AK-5 cells (unpublished obser-
vations). Apoptosis in AK-5 cell is mediated by activated NK 
cells and another as yet unidentified factor present in the 
serum of AK-5 tumor rejecting animals. In addition, DEX 
also induces apoptosis in AK-5 cells. Introduction of CrmA 
(inhibitor for ICE protease) and Nedd-2 in antisense orienta-
tion inhibited the apoptotic activity of AK-5 cells. Similarly 
peptide inhibitors YVAD and DEVD also inhibited apoptosis 
in AK-5 cells. 
In the present study we have investigated the process of the 
cytoplasmic acidification in AK-5 cells undergoing apoptosis. 
There is a 0.2 U change in the [pH]; of AK-5 cells which were 
triggered into apoptosis with either DEX or serum factor 
(Table 1). However, this change in [pH]; was totally abolished 
when AK-5 cells were treated with peptide inhibitor DEVD 
(Table 1), and the change was partial when treated with the 
other peptide inhibitor YVAD, which inhibit apoptosis in 
these cells. Similarly, transfection of AK-5 cells with Nedd-2 
A.S, CrmA or bcl-2 which inhibit the apoptotic process in 
these cells also abolishes cytoplasmic acidification. These re-
sults strongly suggest cytoplasmic acidification as an essential 
requirement for triggering the apoptotic process. The acidifi-
cation may be essential for the activity of acid endonuclease 
(DNase II) which has been implicated in the destruction of the 
genome [4]. Similarly some of the proteases may require a 
lower pH for their optimal activity. 
Bcl-2 has been shown to protect cells against apoptosis 
triggered by a variety of stimuli [26] and bcl-2 also inhibits 
apoptosis in AK-5 cells. In the present study we do not ob-
serve any pH change in the bcl-2 transfected clones suggesting 
again a direct correlation between the cytoplasmic acidifica-
tion and apoptosis of AK-5 cells (Table 2). Thus our present 
results suggest acidification as an essential requirement for the 
cells which are triggered into the apoptotic program and cy-
toplasmic acidification does not occur when anti-apoptotic 
gene bcl-2 and inhibitors of ICE-like proteases are introduced 
into cells. 
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